Indiana University School of Medicine
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Indiana University School of Medicine sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).
Indiana University School of Medicine: 16 sponsored US clinical trials, none currently recruiting.
Indiana University School of Medicine sponsors 16 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 15 completed. 6 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 2 trials.
Top-decile sponsor footprint
Indiana University School of Medicine ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
15 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
16 total, page 1 of 1
Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis
NCT04282317
Nitric Oxide to Treat Pulmonary Embolism
NCT01939301
Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
NCT00875745
Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on Escitalopram
NCT00707863
Study of Paliperidone ER in Adolescents and Young Adults With Autism
NCT00549562
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
NCT00453180
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer
NCT00393341
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
NCT00369889
Aripiprazole Treatment of Bipolar Depression
NCT00198198
The Role of Serotonin in Hot Flashes After Breast Cancer
NCT00228943
Using Informatics to Enhance Care of Older Emergency Department Patients
NCT00297869
Wellbutrin XL Effects on SSRIs Induced Changes
NCT00456820
Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs
NCT00392275
Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
NCT00355446
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
NCT00003107
Arrhythmias in Myotonic Muscular Dystrophy
NCT00622453
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 5 |
Therapeutic Areas
How the Indiana University School of Medicine archive is shaped
16 indexed studies, none listed as recruiting (0% open); 15 completed (94%).
Phase mix: 6 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: Breast Cancer (2 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Indiana University School of Medicine: archived-pipeline peers nationwide
Peers matched on 16 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Indiana University School of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 16 archived trials
- Accelerated Community Oncology Research Network · 16 trials · 0% recruiting
- Altimmune · 16 trials · 6% recruiting
- American University · 16 trials · 13% recruiting
- Anthera Pharmaceuticals · 16 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Indiana University School of Medicine page
16 registered trials is a research-attention snapshot, not an endorsement of Indiana University School of Medicine or any single study.
- None of Indiana University School of Medicine's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Breast Cancer is the condition Indiana University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Indiana University School of Medicine pipeline card: 16 registered trials from official public datasets.Report a data error.